Bharat Biotech to launch Covaxin in Q2 2021

The company's vaccine candidate -Covaxin- has been developed in
collaboration with the Indian Council of Medical Research (ICMR) -
National Institute of Virology (NIV) using inactivated Sars-Cov-2, the
virus that causes COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-launch-covaxin-in-q2-2021/articleshow/78979220.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 30.11.2021 CSIR-IGIB Rs 1.5 Lakh pm Pay Job, ACTREC High Pay

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission